| 研究生: |
劉鈺亭 Liu, Yu-Ting |
|---|---|
| 論文名稱: |
酸誘發慢性肌肉疼痛模型驗證及杏仁核在pregabalin止痛效果扮演之角色 Behavioral validation and the role of amygdala on antinociceptive effects of pregabalin in a rat model of acid-induced chronic muscle pain |
| 指導教授: |
蕭富仁
Shaw, Fu-Zen |
| 共同指導教授: |
吳勝男
Wu, Sheng-Nan |
| 學位類別: |
博士 Doctor |
| 系所名稱: |
醫學院 - 基礎醫學研究所 Institute of Basic Medical Sciences |
| 論文出版年: | 2017 |
| 畢業學年度: | 106 |
| 語文別: | 英文 |
| 論文頁數: | 176 |
| 中文關鍵詞: | 纖維肌痛症 、痛覺過敏 、睡眠障礙 、焦慮 、憂鬱 |
| 外文關鍵詞: | fibromyalgia, hyperalgesia, sleep disturbance, anxiety, depression |
| 相關次數: | 點閱:92 下載:2 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
慢性廣泛肌肉疼痛(CWP),如纖維肌痛症,常伴隨著睡眠障礙、憂鬱及焦慮症
狀,且目前的藥物治療效果有限。本研究目的在評估打酸誘發的疼痛模型是否會類
似於CWP 綜合患者伴隨睡眠障礙、似焦慮憂鬱共病症,而且在此動物模型評估
pregabalin、duloxetine 及diazepam 對機械性痛覺過敏、似焦慮和似憂鬱行為之影響,進而探討pregabalin 治療效果中杏仁核所扮演的角色。本研究使用重複注射酸性溶液到大鼠的單側腓腸肌中引發CWP 症狀,使用von Frey filament 測量腳掌疼痛退縮閾值(paw withdrawal threshold, PWT),肌肉疼痛壓力閾值 (motor pressure threshold, MPT) 使用Randall–Selittou 儀器測量大鼠之機械性痛覺過敏;本研究使用腦電圖客觀評估CWP 大鼠模型的睡眠障礙的發生,並且記錄與分析5 週的24小時清醒睡眠型態;本研究使用架高十字迷宮及開放空間評估似焦慮行為,透過強迫游泳測試,蔗糖消耗和蔗糖偏好測試來測量似憂鬱行為;pregabalin、duloxetine 及 diazepam 採每天口服兩次方式持續進行2 週,以進行疼痛評估與似焦慮憂鬱行為評估。接受酸注射的大鼠顯示廣泛痛覺過敏現象,以及睡眠障礙和似焦慮憂鬱共病症。
pregabalin 組有緩解疼痛、焦慮及不愉悅的症狀;diazepam 組對疼痛無緩解作用但能降低焦慮及不愉悅感的症狀;duloxetine 組有改善疼痛、不愉悅感及絕望的症狀。pregabalin 注射在雙側的杏仁核中央核區(central nucleus, CeA)可減緩重複酸注射引起的痛覺過敏現象,且雙側CeA 給予GV-58 會顯著抑制pregablin 的止痛效果。本研究提供酸誘發肌肉疼痛模型與人類CWP 症狀之完整的表面效度和預測效度分析,而且也發現杏仁核在pregabalin 止痛效果所扮演之不可或缺角色,這些資料相信有助於慢性肌肉疼痛之未來治療發展與產生機制的探討。
Chronic widespread pain (CWP) syndrome is often comorbid with depression, anxiety,and sleep disorder. Because current medication for CWP is unsatisfactory, this study aims to valid a better animal model with CWP syndrome and investigate the role of the amygdala on analgesic effect of pregabalin. The CWP model was elicited by repeatedly injecting an acidic solution into the unilateral gastrocnemius muscle of rats and measured the paw withdrawal
threshold (PWT) and motor pressure threshold (MPT) to assess mechanical hyperalgesia. First, the current study recorded and analyzed 24-h wake-sleep activity for 5 weeks before and after acid-induced hyperalgesia. Obvious sleep disturbance, including increased light sleep and decreased deep sleep as well as occurrence of alpha-delta electroencephalographic pattern in deep sleep, exhibited in the acid-induced CWP model. Second, anxiety-like behavior was evaluated using the open field and elevated plus maze tests, and depression-like behavior was measured using the forced swimming test, sucrose consumption test, and sucrose preference test. The present study provided evidence on
comorbidity of anxiety- and depression-like behaviors in the acid-induced CWP model. Third, predictive validity of pregabalin, duloxetine, and diazepam was investigated in terms of mechanical hyperalgesia and anxio-depressive comorbidity. In the acid-induced CWP model, pregabalin significantly increased PWTs and ameliorated anxiety-like behaviors; Duloxetine significantly increased PWTs and ameliorated depression-like behavior, but didn’t affect anxiety-like behavior; Diazepam remedied anxiety-like and anhedonic behaviors, but didn’t affect mechanical hyperalgesia. Finally, the role of the amygdala was investigated on analgesic effect of pregabalin in the acid-induced CWP model. Pregabalin through gavage or intra-central nucleus of amygdala (CeA) injection significantly alleviated the mechanical and muscle hyperalgesia. Intra-CeA injection of GV-58, a potential calcium III channel agonist, significantly abolished pregablin-induced analgesia. Taken together, the present study provides numerous evidences to validate the acid-induced CWP model as
human with CWP syndromes. The amygdala plays a crucial role in pregabalin-induced analgesia. Our results strengthen importance of the acid-induced CWP model and advance our understandings for pregabalin analgesia.
Aaron LA, Bradley LA, Alarcon GS, Alexander RW, Triana-Alexander M, Martin MY, Alberts KR (1996) Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 39: 436-445.
Ablin J, Neumann L, Buskila D (2008) Pathogenesis of fibromyalgia - a review. Joint Bone Spine 75: 273-279.
Almeida TF, Roizenblatt S, Tufik S (2004) Afferent pain pathways: a neuroanatomical review. Brain Res 1000: 40-56.
Altamura AC, Moliterno D, Paletta S, Maffini M, Mauri MC, Bareggi S (2013) Understanding the pharmacokinetics of anxiolytic drugs. Expert Opin Drug Metab Toxicol 9: 423-440.
Ansah OB, Bourbia N, Goncalves L, Almeida A, Pertovaara A (2010) Influence of amygdaloid glutamatergic receptors on sensory and emotional pain-related behavior in the neuropathic rat. Behav Brain Res 209: 174-178.
Apkarian AV, Bushnell MC, Treede RD, Zubieta JK (2005) Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9: 463-484.
Arendt-Nielsen L, Graven-Nielsen T, Svensson P, Jensen TS (1997) Temporal summation in muscles and referred pain areas: an experimental human study. Muscle & nerve 20: 1311-1313.
Annemans L, Le Lay K, Taieb C (2009) Societal and patient burden of fibromyalgia syndrome. Pharmacoeconomics 27: 547-559.
Arnold LM (2010) The pathophysiology, diagnosis and treatment of fibromyalgia. Psychiatr Clin North Am 33: 375-408.
Arnold LM, Clauw DJ, McCarberg BH, FibroCollaborative (2011) Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 86: 457-464.
Arnold LM, Crofford LJ, Martin SA, Young JP, Sharma U (2007) The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. Pain Med 8: 633-638.
Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV (2006) Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67: 1219-1225.
Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50: 2974-2984.
Aupperle RL, Ravindran L, Tankersley D, Flagan T, Stein NR, Simmons AN, Stein MB, Paulus MP (2011) Pregabalin influences insula and amygdala activation during anticipation of emotional images. Neuropsychopharmacology 36: 1466-1477.
Aupperle RL, Tankersley D, Ravindran LN, Flagan T, Stein NR, Stein MB, Paulus MP (2012) Pregabalin effects on neural response to emotional faces. Front Hum Neurosci 6: 42.
Baastrup C, Jensen TS, Finnerup NB (2011) Pregabalin attenuates place escape/avoidance behavior in a rat model of spinal cord injury. Brain Res 1370: 129-135.
Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D (2012) Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012: 426130.
Benedetti F, Amanzio M, Vighetti S, Asteggiano G (2006) The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 26: 12014-12022.
Benjamin S, Morris S, McBeth J, Macfarlane GJ, Silman AJ (2000) The association between chronic widespread pain and mental disorder: a population-based study. Arthritis Rheum 43: 561-567.
Benedetti F, Amanzio M, Vighetti S, Asteggiano G (2006) The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 26: 12014-12022.
Bian F, Li Z, Offord J, Davis MD, McCormick J, Taylor CP, Walker LC (2006) Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice. Brain Res 1075: 68-80.
Bingel U, Quante M, Knab R, Bromm B, Weiller C, Buchel C (2002) Subcortical structures involved in pain processing: evidence from single-trial fMRI. Pain 99: 313-321.
Bjorvatn B, Fagerland S, Ursin R (1998) EEG power densities (0.5-20 Hz) in different sleep-wake stages in rats. Physiol Behav 63: 413-417.
Blackburn-Munro G (2004) Pain-like behaviours in animals - how human are they? Trends Pharmacol Sci 25: 299-305.
Burgmer M, Gaubitz M, Konrad C, Wrenger M, Hilgart S, Heuft G, Pfleiderer B (2009) Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med 71: 566-573.
Burns JW, Crofford LJ, Chervin RD (2008) Sleep stage dynamics in fibromyalgia patients and controls. Sleep Medicine 9: 689-696.
Bushnell MC, Duncan GH, Hofbauer RK, Ha B, Chen JI, Carrier B (1999) Pain perception: is there a role for primary somatosensory cortex? Proc Natl Acad Sci U S A 96: 7705-7709.
Carrasquillo Y, Gereau RWt (2008) Hemispheric lateralization of a molecular signal for pain modulation in the amygdala. Mol Pain 4: 24.
C-ote KA, Moldofsky H (1997) Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia. The Journal of Rheumatology 24: 2014-2023.
Campbell SS, Tobler I (1984) Animal sleep: a review of sleep duration across phylogeny. Neurosci Biobehav Rev 8: 269-300.
Carden SE, Coons EE (1990) Diazepam's impact on self-stimulation but not stimulation-escape suggests hedonic modulation. Behav Neurosci 104: 56-61.
Chakrabarty S, Zoorob R (2007) Fibromyalgia. Am Fam Physician 76: 247-254.
Chen WK, Liu IY, Chang YT, Chen YC, Chen CC, Yen CT, Shin HS, Chen CC (2010) Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain. J Neurosci 30: 10360-10368.
Cheng SJ, Chen CC, Yang HW, Chang YT, Bai SW, Chen CC, Yen CT, Min MY (2011) Role of extracellular signal-regulated kinase in synaptic transmission and plasticity of a nociceptive input on capsular central amygdaloid neurons in normal and acid-induced muscle pain mice. Journal of Neuroscience 31: 2258-2270.
Choy EH (2016) Current treatments to counter sleep dysfunction as a pathogenic stimulus of fibromyalgia. Pain Management 6: 339-346.
Cifre I, Sitges C, Fraiman D, Munoz MA, Balenzuela P, Gonzalez-Roldan A, Martinez-Jauand M, Birbaumer N, Chialvo DR, Montoya P (2012) Disrupted functional connectivity of the pain network in fibromyalgia. Psychosom Med 74: 55-62.
Clauw DJ (2009) Fibromyalgia: an overview. Am J Med 122: S3-S13.
Cole RL, Lechner SM, Williams ME, Prodanovich P, Bleicher L, Varney MA, Gu G (2005) Differential distribution of voltage-gated calcium channel alpha-2 delta (alpha2delta) subunit mRNA-containing cells in the rat central nervous system and the dorsal root ganglia. J Comp Neurol 491: 246-269.
Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29: 547-569.
DeSantana JM, da Cruz KM, Sluka KA (2013) Animal models of fibromyalgia. Arthritis Res Ther 15: 222.
DeSantana JM, Sluka KA (2008) Central mechanisms in the maintenance of chronic widespread noninflammatory muscle pain. Curr Pain Headache Rep 12: 338-343.
Dina OA, Levine JD, Green PG (2011) Enhanced cytokine-induced mechanical hyperalgesia in skeletal muscle produced by a novel mechanism in rats exposed to unpredictable sound stress. Eur J Pain 15: 796-800.
Ding L, Cai J, Guo XY, Meng XL, Xing GG (2014) The antiallodynic action of pregabalin may depend on the suppression of spinal neuronal hyperexcitability in rats with spared nerve injury. Pain Res Manag 19: 205-211.
Deyama S, Takishita A, Tanimoto S, Ide S, Nakagawa T, Satoh M, Minami M (2010) Roles of beta- and alpha2-adrenoceptors within the central nucleus of the amygdala in the visceral pain-induced aversion in rats. J Pharmacol Sci 114: 123-126.
Dooley DJ, Donovan CM, Meder WP, Whetzel SZ (2002) Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices. Synapse 45: 171-190.
Ebner K, Muigg P, Singewald G, Singewald N (2008) Substance P in stress and anxiety: NK-1 receptor antagonism interacts with key brain areas of the stress circuitry. Ann N Y Acad Sci 1144: 61-73.
Ehrlich I, Humeau Y, Grenier F, Ciocchi S, Herry C, Luthi A (2009) Amygdala inhibitory circuits and the control of fear memory. Neuron 62: 757-771.
Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, Kuck J, Leslie V, Masur D, Wagner M, Waid R, Zisook S (1999) Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40: 57-63.
Fehrenbacher JC, Taylor CP, Vasko MR (2003) Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 105: 133-141.
Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, Clusmann H, Gothert M (2002) Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42: 229-236.
Foerster BR, Petrou M, Edden RA, Sundgren PC, Schmidt-Wilcke T, Lowe SE, Harte SE, Clauw DJ, Harris RE (2012) Reduced insular gamma-aminobutyric acid in fibromyalgia. Arthritis Rheum 64: 579-583.
Fogel SM, Smith CT, Cote KA (2007) Dissociable learning-dependent changes in REM and non-REM sleep in declarative and procedural memory systems. Behav Brain Res 180: 48-61.
Goncalves L, Dickenson AH (2012) Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation. Eur J Neurosci 36: 3204-3213.
Gracely RH, Ceko M, Bushnell MC (2012) Fibromyalgia and depression. Pain Res Treat 2012: 486590.
Gran JT (2003) The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17: 547-561.
Green PG, Alvarez P, Gear RW, Mendoza D, Levine JD (2011) Further validation of a model of fibromyalgia syndrome in the rat. J Pain 12: 811-818.
Gregoire S, Michaud V, Chapuy E, Eschalier A, Ardid D (2012) Study of emotional and cognitive impairments in mononeuropathic rats: effect of duloxetine and gabapentin. Pain 153: 1657-1663.
Harding SM (1998) Sleep in fibromyalgia patients: subjective and objective findings. Am J Med Sci 315: 367-376.
Harman K, Pivik RT, D'Eon JL, Wilson KG, Swenson JR, Matsunaga L (2002) Sleep in depressed and nondepressed participants with chronic low back pain: electroencephalographic and behaviour findings. Sleep 25: 775-783.
Harris RE, Napadow V, Huggins JP, Pauer L, Kim J, Hampson J, Sundgren PC, Foerster B, Petrou M, Schmidt-Wilcke T, Clauw DJ (2013) Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology 119: 1453-1464.
Harris RE, Sundgren PC, Pang Y, Hsu M, Petrou M, Kim SH, McLean SA, Gracely RH, Clauw DJ (2008) Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 58: 903-907.
Harstall C, Ospina M (2003) How Prevalent Is Chronic Pain? Pain Clinical Updates 11: 1-4.
Hauser W, Bernardy K, Uceyler N, Sommer C (2009) Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials. Pain 145: 69-81.
Haviland MG, Banta JE, Przekop P (2011) Fibromyalgia: prevalence, course, and co-morbidities in hospitalized patients in the United States, 1999-2007. Clin Exp Rheumatol 29: S79-87.
Helmstetter FJ (1992) The amygdala is essential for the expression of conditional hypoalgesia. Behav Neurosci 106: 518-528.
Hofbauer RK, Rainville P, Duncan GH, Bushnell MC (2001) Cortical representation of the sensory dimension of pain. J Neurophysiol 86: 402-411.
Huang HY, Lee HW, Chen SD, Shaw FZ (2012) Lamotrigine ameliorates seizures and psychiatric comorbidity in a rat model of spontaneous absence epilepsy. Epilepsia 53: 2005-2014.
Huang J, Kang XZ, Luo P (2005) [Involvement of amygdala in the emotional processing of pain]. Sheng Li Ke Xue Jin Zhan 36: 289-294.
Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Fitzgerald JD, Ranganath VK, Nicassio PM (2012) Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 35: 537-543.
Jeong HJ, Mitchell VA, Vaughan CW (2012) Role of 5-HT(1) receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn. Br J Pharmacol 165: 1956-1965.
Ji G, Neugebauer V (2009) Hemispheric lateralization of pain processing by amygdala neurons. J Neurophysiol 102: 2253-2264.
Ji RR, Baba H, Brenner GJ, Woolf CJ (1999) Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 2: 1114-1119.
Kalynchuk LE (2000) Long-term amygdala kindling in rats as a model for the study of interictal emotionality in temporal lobe epilepsy. Neurosci Biobehav Rev 24: 691-704.
Kim JY, Kim SH, Seo J, Kim SH, Han SW, Nam EJ, Kim SK, Lee HJ, Lee SJ, Kim YT, Chang Y (2013) Increased power spectral density in resting-state pain-related brain networks in fibromyalgia. Pain 154: 1792-1797.
Kim SH, Song J, Mun H, Park KU (2009) Effect of the combined use of tramadol and milnacipran on pain threshold in an animal model of fibromyalgia. Korean J Intern Med 24: 139-142.
Kroenke K, Jackson JL, Chamberlin J (1997) Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am J Med 103: 339-347.
La Porta C, Lara-Mayorga IM, Negrete R, Maldonado R (2016) Effects of pregabalin on the nociceptive, emotional and cognitive manifestations of neuropathic pain in mice. Eur J Pain 20: 1454-1466.
Lentz MJ, Landis CA, Rothermel J, Shaver JL (1999) Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. The Journal of Rheumatology 26: 1586-1592.
Li W, Neugebauer V (2004) Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain. Pain 110: 112-122.
Lutz J, Jager L, de Quervain D, Krauseneck T, Padberg F, Wichnalek M, Beyer A, Stahl R, Zirngibl B, Morhard D, Reiser M, Schelling G (2008) White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum 58: 3960-3969.
Manning BH, Mayer DJ (1995) The central nucleus of the amygdala contributes to the production of morphine antinociception in the rat tail-flick test. The Journal of Neuroscience 15: 8199-8213.
Manning BH (1998) A lateralized deficit in morphine antinociception after unilateral inactivation of the central amygdala. J Neurosci 18: 9453-9470.
Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP, Jr., Martin SA, Sharma U (2008) A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 35: 502-514.
Martinez JE, Ferraz MB, Fontana AM, Atra E (1995) Psychological aspects of Brazilian women with fibromyalgia. J Psychosom Res 39: 167-174.
Miranda A, Peles S, McLean PG, Sengupta JN (2006) Effects of the 5-HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesia. Pain 126: 54-63.
Mistlberger RE, Bergmann BM, Waldenar W, Rechtschaffen A (1983) Recovery sleep following sleep deprivation in intact and suprachiasmatic nuclei-lesioned rats. Sleep 6: 217-233.
Mitchell MR, Vokes CM, Blankenship AL, Simon NW, Setlow B (2011) Effects of acute administration of nicotine, amphetamine, diazepam, morphine, and ethanol on risky decision-making in rats. Psychopharmacology 218: 703-712.
Moldofsky H (2001) Sleep and pain. Sleep Med Rev 5: 385-396.
Moldofsky H, Scarisbrick P, England R, Smythe H (1975) Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 37: 341-351.
Molle M, Bergmann TO, Marshall L, Born J (2011) Fast and slow spindles during the sleep slow oscillation: disparate coalescence and engagement in memory processing. Sleep 34: 1411-1421.
Munro G, Lopez-Garcia JA, Rivera-Arconada I, Erichsen HK, Nielsen EO, Larsen JS, Ahring PK, Mirza NR (2008) Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 327: 969-981.
Nagakura Y, Oe T, Aoki T, Matsuoka N (2009) Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Pain 146: 26-33.
Nagakura Y, Takahashi M, Noto T, Sekizawa T, Oe T, Yoshimi E, Tamaki K, Shimizu Y (2012) Different pathophysiology underlying animal models of fibromyalgia and neuropathic pain: comparison of reserpine-induced myalgia and chronic constriction injury rats. Behav Brain Res 226: 242-249.
Nasu T, Taguchi T, Mizumura K (2010) Persistent deep mechanical hyperalgesia induced by repeated cold stress in rats. Eur J Pain 14: 236-244.
Neckelmann D, Olsen OE, Fagerland S, Ursin R (1994) The reliability and functional validity of visual and semiautomatic sleep/wake scoring in the Moll-Wistar rat. Sleep 17: 120-131.
Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13: 1161-1169.
Neugebauer V (2015) Amygdala pain mechanisms. Handb Exp Pharmacol 227: 261-284.
Neugebauer V, Li W, Bird GC, Han JS (2004) The amygdala and persistent pain. Neuroscientist 10: 221-234.
Nielsen AN, Mathiesen C, Blackburn-Munro G (2004) Pharmacological characterisation of acid-induced muscle allodynia in rats. Eur J Pharmacol 487: 93-103.
Nishiyori M, Uchida H, Nagai J, Araki K, Mukae T, Kishioka S, Ueda H (2011) Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants. Mol Pain 7: 69.
Nishiyori M, Ueda H (2008) Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Mol Pain 4: 52.
North JM, Hong KS, Rauck RL (2016) The effect of a novel form of extended-release gabapentin on pain and sleep in fibromyalgia subjects: An open-label pilot study. Pain Ppractice 16: 720-729.
Okifuji A, Turk DC (2006) Sex hormones and pain in regularly menstruating women with fibromyalgia syndrome. J Pain 7: 851-859.
Palazzo E, Fu Y, Ji G, Maione S, Neugebauer V (2008) Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors. Neuropharmacology 55: 537-545.
Parent AJ, Beaudet N, Beaudry H, Bergeron J, Berube P, Drolet G, Sarret P, Gendron L (2012) Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behav Brain Res 229: 160-167.
Patel S, Kale PP, Addepalli V, Sarkar A, Savai J (2015) Effect of a combination of duloxetine with hydroxyzine on experimental models of anxiety in mice. Indian J Pharmacol 47: 173-176.
Pedersen LH, Scheel-Kruger J, Blackburn-Munro G (2007) Amygdala GABA-A receptor involvement in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury. Pain 127: 17-26.
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149-167.
Phillips K, Clauw DJ (2013) Central pain mechanisms in the rheumatic diseases: future directions. Arthritis Rheum 65: 291-302.
Ploner M, Gross J, Timmermann L, Schnitzler A (2002) Cortical representation of first and second pain sensation in humans. Proc Natl Acad Sci U S A 99: 12444-12448.
Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463: 3-33.
Pyke TL, Osmotherly PG, Baines S (2017) Measuring Glutamate Levels in the Brains of Fibromyalgia Patients and a Potential Role for Glutamate in the Pathophysiology of Fibromyalgia Symptoms: A Systematic Review. Clin J Pain 33: 944-954.
Quijada-Carrera J, Valenzuela-Castano A, Povedano-Gomez J, Fernandez-Rodriguez A, Hernanz-Mediano W, Gutierrez-Rubio A, de la Iglesia-Salgado JL, Garcia-Lopez A (1996) Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. Pain 65: 221-225.
Rashvand M, Khajavai A, Parviz M, Hasanein P, Keshavarz M (2014) GABAA receptors are involved in the analgesic effects of morphine microinjected into the central nucleus of the amygdala. Clin Exp Pharmacol Physiol 41: 338-344.
Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22: 659-661.
Reynolds LM, Engin E, Tantillo G, Lau HM, Muschamp JW, Carlezon WA, Jr., Rudolph U (2012) Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward. Neuropsychopharmacology 37: 2531-2540.
Rodgers RJ, Dalvi A (1997) Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 21: 801-810.
Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S (2001) Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 44: 222-230.
Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM (2008) Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136: 432-444.
Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, Lopez Y, MacKillip F (1994) Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37: 1593-1601.
Russell IJ, Vaeroy H, Javors M, Nyberg F (1992) Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35: 550-556.
Sarchielli P, Di Filippo M, Nardi K, Calabresi P (2007) Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep 11: 343-351.
Sarkisova KY, Kuznetsova GD, Kulikov MA, van Luijtelaar G (2010) Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms. Epilepsia 51: 146-160.
Sarzi-Puttini P, Rizzi M, Andreoli A, Panni B, Pecis M, Colombo S, Turiel M, Carrabba M, Sergi M (2002) Hypersomnolence in fibromyalgia syndrome. Clin Exp Rheumatol 20: 69-72.
Shaw FZ (2004) Is spontaneous high-voltage rhythmic spike discharge in Long Evans rats an absence-like seizure activity? Journal of Neurophysiology 91: 63-77.
Shaw FZ, Chuang SH, Shieh KR, Wang YJ (2009) Depression- and anxiety-like behaviors of a rat model with absence epileptic discharges. Neuroscience 160: 382-393.
Shaw FZ, Lai CJ, Chiu TH (2002) A low-noise flexible integrated system for recording and analysis of multiple electrical signals during sleep-wake states in rats. Journal of Neuroscience Methods 118: 77-87.
Shaw FZ, Lee SY, Chiu TH (2006) Modulation of somatosensory evoked potentials during wake-sleep states and spike-wave discharges in the rat. Sleep 29: 285-293.
Sluka KA, Clauw DJ (2016) Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 338: 114-129.
Sluka KA, Kalra A, Moore SA (2001) Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 24: 37-46.
Sluka KA, Price MP, Breese NM, Stucky CL, Wemmie JA, Welsh MJ (2003) Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain 106: 229-239.
Sluka KA, Radhakrishnan R, Benson CJ, Eshcol JO, Price MP, Babinski K, Audette KM, Yeomans DC, Wilson SP (2007) ASIC3 in muscle mediates mechanical, but not heat, hyperalgesia associated with muscle inflammation. Pain 129: 102-112.
Sluka KA, Rohlwing JJ, Bussey RA, Eikenberry SA, Wilken JM (2002) Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists. J Pharmacol Exp Ther 302: 1146-1150.
Stening KD, Eriksson O, Henriksson KG, Brynhildsen J, Lindh-Astrand L, Berg G, Hammar M, Amandusson A, Blomqvist A (2011) Hormonal replacement therapy does not affect self-estimated pain or experimental pain responses in post-menopausal women suffering from fibromyalgia: a double-blind, randomized, placebo-controlled trial. Rheumatology (Oxford) 50: 544-551.
Sun GC, Hsu MC, Chia YY, Chen PY, Shaw FZ (2008) Effects of age and gender on intravenous midazolam premedication: a randomized double-blind study. Br J Anaesth 101: 632-639.
Suzuki T, Amata M, Sakaue G, Nishimura S, Inoue T, Shibata M, Mashimo T (2007) Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression. Anesth Analg 104: 1570-1577.
Tarr TB, Malick W, Liang M, Valdomir G, Frasso M, Lacomis D, Reddel SW, Garcia-Ocano A, Wipf P, Meriney SD (2013) Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndrome. The Journal of Neuroscience 33: 10559-10567.
Taylor CP, Garrido R (2008) Immunostaining of rat brain, spinal cord, sensory neurons and skeletal muscle for calcium channel alpha2-delta (alpha2-delta) type 1 protein. Neuroscience 155: 510-521.
Terburg D, Syal S, Rosenberger LA, Heany S, Phillips N, Gericke N, Stein DJ, van Honk J (2013) Acute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus. Neuropsychopharmacology 38: 2708-2716.
Thieme K, Turk DC, Flor H (2004) Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 66: 837-844.
Tillu DV, Gebhart GF, Sluka KA (2008) Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insult. Pain 136: 331-339.
Tirgar F, Rezayof A, Zarrindast MR (2014) Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia. Neuroscience 277: 392-402.
Toda K (2007) The prevalence of fibromyalgia in Japanese workers. Scand J Rheumatol 36: 140-144.
Toussaint M, Luthringer R, Schaltenbrand N, Carelli G, Lainey E, Jacqmin A, Muzet A, Macher JP (1995) First-night effect in normal subjects and psychiatric inpatients. Sleep 18: 463-469.
Treede RD, Kenshalo DR, Gracely RH, Jones AK (1999) The cortical representation of pain. Pain 79: 105-111.
Vaeroy H, Helle R, Forre O, Kass E, Terenius L (1988) Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 32: 21-26.
Valdes M, Collado A, Bargallo N, Vazquez M, Rami L, Gomez E, Salamero M (2010) Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study. Arthritis Rheum 62: 1829-1836.
Veinante P, Yalcin I, Barrot M (2013) The amygdala between sensation and affect: a role in pain. J Mol Psychiatry 1: 9.
Verma V, Singh N, Singh Jaggi A (2014) Pregabalin in neuropathic pain: evidences and possible mechanisms. Curr Neuropharmacol 12: 44-56.
Vierck CJ, Jr. (2006) Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain 124: 242-263.
Wallace VC, Segerdahl AR, Blackbeard J, Pheby T, Rice AS (2008) Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain. Neurosci Lett 448: 153-156.
Wang SH, Zhang ZJ, Guo YJ, Zhou H, Teng GJ, Chen BA (2009) Anhedonia and activity deficits in rats: impact of post-stroke depression. J Psychopharmacol 23: 295-304.
West AP (1990) Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 14: 863-877.
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38: 19-28.
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33: 160-172.
Yasenkov R, Deboer T (2012) Circadian modulation of sleep in rodents. Prog Brain Res 199: 203-218.
Yokoyama T, Maeda Y, Audette KM, Sluka KA (2007) Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. J Pain 8: 422-429.
Young CP, Liang SF, Chang DW, Liao YC, Shaw FZ, Hsieh CH (2011) A portable wireless online closed-loop seizure controller in freely moving rats. IEEE Transactions on Instrumentation and Measurement 60: 513-521.
Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC (1992) Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 19: 90-94.
Zaratin P, Angelici O, Clarke GD, Schmid G, Raiteri M, Carita F, Bonanno G (2000) NK3 receptor blockade prevents hyperalgesia and the associated spinal cord substance P release in monoarthritic rats. Neuropharmacology 39: 141-149.
校內:2023-02-08公開